Automating Surveillance for the Analysis of Adverse Event Case Reports

被引:0
|
作者
Lionel O. Benson
Linda Marc
机构
[1] Astra Merck Inc.,Clinical Operations & Product Safety
[2] Astra Merck Inc.,Product Safety & Epidemiology
关键词
Adverse event; Surveillance; Computer assisted surveillance;
D O I
暂无
中图分类号
学科分类号
摘要
The traditional method of manually reviewing large numbers of adverse event reports is not conducive to efficiently maintaining an up-to-date safety profile of a drug or to rapidly responding to inquiries on adverse events. The development of a computerized system was undertaken to perform the preliminary scrutiny of enormous quantities of information by evaluating the unique contents of each case report and quantifying the results. This paper will focus on how a computerized surveillance system identifies, in a patient’s record, concomitant drugs and preexisting medical conditions known to be associated with the adverse event under surveillance. The automated capability is not meant to replace the function of the expert medical reviewer but to assist in rapidly drawing attention to case reports that require further skilled review. Automating surveillance can improve the quality of AE review and also allow more efficient use of limited resources.
引用
收藏
页码:825 / 832
页数:7
相关论文
共 50 条
  • [41] Adverse Event Reports Associated with Vaginal Mesh: An Interrupted Time Series Analysis
    Leiter, Valerie
    White, Shelley K.
    Walters, Abigail
    WOMENS HEALTH ISSUES, 2017, 27 (03) : 279 - 285
  • [43] Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports
    Phuong Pham
    Cheng, Carmen
    Wu, Eileen
    Kim, Ivone
    Zhang, Rongmei
    Ma, Yong
    Kortepeter, Cindy M.
    Munoz, Monica A.
    PHARMACEUTICAL MEDICINE, 2021, 35 (05) : 307 - 316
  • [44] Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation
    Marder, Stephen R.
    Sorsaburu, Sebastian
    Dunayevich, Eduardo
    Karagianis, Jamie L.
    Dawe, Ian C.
    Falk, Deborah M.
    Dellva, Mary Anne
    Carlson, Janice L.
    Cavazzoni, Patrizia A.
    Baker, Robert W.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (04) : 433 - 441
  • [45] Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports
    Phuong Pham
    Carmen Cheng
    Eileen Wu
    Ivone Kim
    Rongmei Zhang
    Yong Ma
    Cindy M. Kortepeter
    Monica A. Muñoz
    Pharmaceutical Medicine, 2021, 35 : 307 - 316
  • [46] Adverse event profile of setmelanotide in obesity: an integrated assessment and systematic review using disproportionality analysis, case reports and meta-analysis
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [47] AN OVERVIEW OF THE VHA INJURY AND ADVERSE EVENT SURVEILLANCE SYSTEM
    Campbell, R. R.
    French, D.
    Lapcevic, W. A.
    Spehar, A. M.
    Powell-Cope, G.
    GERONTOLOGIST, 2010, 50 : 46 - 46
  • [48] Study of a multisite prospective adverse event surveillance system
    Forster, Alan J.
    Huang, Allen
    Lee, Todd C.
    Jennings, Alison
    Choudhri, Omer
    Backman, Chantal
    BMJ QUALITY & SAFETY, 2020, 29 (04) : 277 - 285
  • [49] A Comparison of Active Adverse Event Surveillance Systems Worldwide
    Huang, Yu-Lin
    Moon, Jinhee
    Segal, Jodi B.
    DRUG SAFETY, 2014, 37 (08) : 581 - 596
  • [50] A Comparison of Active Adverse Event Surveillance Systems Worldwide
    Yu-Lin Huang
    Jinhee Moon
    Jodi B. Segal
    Drug Safety, 2014, 37 : 581 - 596